Clinuvel Pharmaceuticals | CUV - Net Income

Stock Price
9.32
Daily Change
0.31 3.44%
Monthly
-6.80%
Yearly
-7.45%
Q2 Forecast
8.82

Clinuvel Pharmaceuticals reported AUD10.44M in Net Income for its fiscal semester ending in December of 2025.





Net Income Change Date
Avita Medical AUD -11.62M 1.7M Dec/2025
Medical Developments International AUD -226K 121K Dec/2025
Mesoblast USD -40.16M 14.05M Dec/2025
Neuren Pharmaceuticals AUD 15.4M 7.88M Dec/2025
Pacific Edge NZD -19.12M 3.68M Dec/2025
Paradigm Biopharmaceuticals AUD -23.24M 16.82M Dec/2025
PYC Therapeutics AUD -22.83M 10.46M Dec/2025
Telix Pharmaceuticals AUD -4.83M 2.54M Dec/2025